Current Protein Identity:P24530 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
5X93 Human endothelin receptor type-B in complex with antagonist K-8794 Deposited 2017-03-05 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:R124Y,D154A,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A K87 3-[6-[(4-tert-butylphenyl)sulfonylamino]-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]oxy-N-(2,6-dimethylphenyl)propanamide × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 11 CLR CHOLESTEROL × 1 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, (NH4)2SO4, MOPS
Resolution 2.20 Å R-free 0.239
5XPR Human endothelin receptor type-B in complex with antagonist bosentan Deposited 2017-06-04 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:R124Y,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,K270A,C1054A,I1094R,S342A,I381A,C396A,C400A,C405A K86 4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide × 1 SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500 DME, Na2SO4, MOPS
Resolution 3.60 Å R-free 0.297
6IGK Crystal Structure of human ETB receptor in complex with Endothelin-3 Deposited 2018-09-25 Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 12 CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 6;293 K;PEG 500DME, Ammonium citrate tribasic
Resolution 2.00 Å R-free 0.227
6IGL Crystal Structure of human ETB receptor in complex with IRL1620 Deposited 2018-09-25 Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A CIT CITRIC ACID × 1 SO4 SULFATE ION × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 3 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 5;293 K;PEG 500DME, (NH4)2SO4 or NH4Cl
Resolution 2.70 Å R-free 0.241
6K1Q Human endothelin receptor type-B in complex with inverse agonist IRL2500 Deposited 2019-05-11 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:;R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A ; Mutation:;R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A,R124Y, K270A,C97A, I137R,S342A, I381A, C396A, C400A, C405A ; D2U (2~{S})-2-[[(2~{R})-2-[(3,5-dimethylphenyl)carbonyl-methyl-amino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid × 1 PO4 PHOSPHATE ION × 4 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 8 X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 7.5;293 K;30% PEG300, 150 mM NaH2PO4,10 mM TCEP, 100 mM Bis-tris
Resolution 2.70 Å R-free 0.265
6LRY Crystal structure of human endothelin ETB receptor in complex with sarafotoxin S6b Deposited 2020-01-16 Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 66–303(238 aa)
Chain A 311–407(97 aa)
Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A Mutation:R124Y,D154A,K270A,C1052T,C1095A,S342A,I381A,C396A,C400A,C405A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions LIPIDIC CUBIC PHASE;pH 5;293 K;PEG 600, Ammonium sulfate
Resolution 3.00 Å R-free 0.304
8HBD Cryo-EM structure of IRL1620-bound ETBR-Gi complex Deposited 2022-10-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 27–424(398 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.04
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.99 Å
8HCX Cryo-EM structure of Endothelin1-bound ETBR-Gq complex Deposited 2022-11-03 Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain C 27–424(398 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.50 Å
8XVE Cryo-EM structure of ETBR bound with BQ3020 Deposited 2024-01-15 Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 67–406(340 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.00 Å
8XVH Cryo-EM structure of ETBR bound with Endothelin1 Deposited 2024-01-15 Assembly 1 Insufficient information Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 67–406(340 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.26 Å
8XWP Cryo-EM structure of ET-1 bound ETBR-DNGI complex Deposited 2024-01-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 66–407(342 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.21 Å
8XWQ Cryo-EM structure of ET-1 bound ETBR-DNGI complex Deposited 2024-01-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 66–407(342 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 4.60 Å
8ZRT Cryo-EM structure focused on the receptor of the ET-1 bound ETBR-DNGI complex Deposited 2024-06-05 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain R 66–407(342 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.62 Å